{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:59:08Z","timestamp":1761742748418},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.amjcard.2006.03.006","type":"journal-article","created":{"date-parts":[[2006,4,18]],"date-time":"2006-04-18T19:18:47Z","timestamp":1145387927000},"page":"26-33","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S1","title":["Improving Outcomes in Post\u2013Acute Myocardial Infarction Heart Failure: Incorporation of Aldosterone Blockade into Combination Therapy to Optimize Neurohormonal Blockade"],"prefix":"10.1016","volume":"97","author":[{"given":"Bertram","family":"Pitt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai","family":"Gheorghiade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash C.","family":"Deedwania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Duprez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2006.03.006_bib1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2006.03.006_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.03.006_bib3","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2006.03.006_bib4","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction","volume":"333","author":"K\u00f8ber","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.03.006_bib5","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2006.03.006_bib6","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.03.006_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199808203390801","article-title":"Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction","volume":"339","author":"Gottlieb","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.03.006_bib8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2006.03.006_bib9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0002-8703(03)00163-7","article-title":"Metoprolol CR\/XL in postmyocardial infarction patients with chronic heart failure","volume":"146","author":"Janosi","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2006.03.006_bib10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.03.006_bib11","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0735-1097(02)02173-3","article-title":"Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction","volume":"40","author":"Wu","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2006.03.006_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1067\/mhj.2003.53","article-title":"Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction","volume":"145","author":"Hasdai","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2006.03.006_bib13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.CIR.0000109691.16944.DA","article-title":"Determinants and prognostic impact of heart failure complicating acute coronary syndromes","volume":"109","author":"Steg","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.03.006_bib14","series-title":"Harrison\u2019s Principles of Internal Medicine","first-page":"1316","article-title":"Normal and abnormal myocardial function","author":"Braunwald","year":"2001"},{"key":"10.1016\/j.amjcard.2006.03.006_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM198807143190204","article-title":"Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction","volume":"319","author":"Pfeffer","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.03.006_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(88)90347-9","article-title":"Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction","volume":"1","author":"Sharpe","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2006.03.006_bib17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.0000134791.68010.FA","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction\u2014executive summary","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.03.006_bib18","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/CIRCULATIONAHA.105.167587","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.03.006_bib19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2006.03.006_bib20","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1001\/jama.1983.03340200048027","article-title":"A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results","volume":"250","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2006.03.006_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.CIR.73.3.503","article-title":"Effect of propranolol after acute myocardial infarction in patients with congestive heart failure","volume":"73","author":"Chadda","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.03.006_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1677\/joe.0.0910457","article-title":"Rise in plasma concentration of aldosterone during long-term angiotensin II suppression","volume":"91","author":"Staessen","year":"1981","journal-title":"J Endocrinol"},{"key":"10.1016\/j.amjcard.2006.03.006_bib23","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/hrt.2003.025312","article-title":"Aldosterone blockade in cardiovascular disease","volume":"90","author":"Struthers","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2006.03.006_bib24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0735-1097(01)01539-X","article-title":"Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction","volume":"38","author":"Hayashi","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2006.03.006_bib25","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.03.006_bib26","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/euhj.1998.1093","article-title":"Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) study","volume":"19","author":"Vantrimpont","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2006.03.006_bib27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.03.006_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacc.2005.04.038","article-title":"Eplerenone reduces mortality 30 days post-randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure","volume":"46","author":"Pitt","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2006.03.006_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejheart.2005.11.008","article-title":"Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction \u226430%","author":"Pitt","year":"2006","journal-title":"Eur J Heart Fail"},{"issue":"suppl","key":"10.1016\/j.amjcard.2006.03.006_bib30","first-page":"599","article-title":"The EPHESUS trial","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"issue":"suppl 2","key":"10.1016\/j.amjcard.2006.03.006_bib31","first-page":"A116","article-title":"Eplerenone is safe and effective in diabetic patients with post-acute myocardial infarction heart failure","volume":"53","author":"O\u2019Keefe","year":"2004","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.1016\/j.amjcard.2006.03.006_bib32","first-page":"79","article-title":"Eplerenone benefit at 30 days in high-risk subgroups in the EPHESUS trial","volume":"4","author":"van Veldhuisen","year":"2005","journal-title":"Eur J Heart Fail"},{"issue":"suppl","key":"10.1016\/j.amjcard.2006.03.006_bib33","first-page":"S156","article-title":"Favorable outcomes with 25 mg of eplerenone in patients with post-AMI heart failure","volume":"11","author":"Banas","year":"2005","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.amjcard.2006.03.006_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0735-1097(02)02694-3","article-title":"Complications of inappropriate use of spironolactone in heart failure","volume":"41","author":"Bozkurt","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2006.03.006_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.03.006_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jama.293.4.437","article-title":"Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction","volume":"293","author":"Mehta","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2006.03.006_bib37","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0002-9149(00)01519-8","article-title":"Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)","volume":"87","author":"Fonarow","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.03.006_bib38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/01.SMJ.0000060581.77206.ED","article-title":"Effectiveness of the clinical pathway in the management of congestive heart failure","volume":"96","author":"Ranjan","year":"2003","journal-title":"South Med J"},{"issue":"suppl 1","key":"10.1016\/j.amjcard.2006.03.006_bib39","first-page":"S45","article-title":"Strategies to improve the use of evidence-based heart failure therapies","volume":"5","author":"Fonarow","year":"2004","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2006.03.006_bib40","first-page":"339A","article-title":"Does patient age impact the use of evidence-based heart failure therapies at hospital discharge? A report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"45","author":"Fonarow","year":"2005","journal-title":"J Am Coll Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914906004619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914906004619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T05:01:12Z","timestamp":1547701272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914906004619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0002914906004619"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2006.03.006","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}